Science Explorer Back to mapMap

Breast Cancer Treatment Studies

Breast Cancer Treatment Studies is a research topic within Cancer Research. Science Explorer counts 54k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on molecular research, treatment response, and prognostic markers in breast cancer. It covers topics such as gene expression patterns, molecular subtypes, neoadjuvant therapy, radiotherapy, and the impact of hormone receptors on survival. The papers also discuss the development of clinical practice guidelines for breast cancer management.

  • Gene Expression
  • Breast Tumours
  • Treatment Response
  • Molecular Subtypes
  • Prognostic Markers
  • Neoadjuvant Therapy
  • Radiotherapy
  • Hormone Receptors
  • Survival Analysis
  • Clinical Practice Guidelines
Research works
54k
fractional, since 1950
In the world top 10%
5.5k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
United States
33% of the 10 largest, 2022-now

Which countries lead Breast Cancer Treatment Studies research?

By volume, the United States and China publish the most (2.7k and 1.9k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.7k works
  2. 2 China 1.9k works
  3. 3 India 648 works
  4. 4 United Kingdom 607 works
  5. 5 Italy 519 works
  6. 6 Japan 420 works
  7. 7 Germany 403 works
  8. 8 South Korea 356 works
  9. 9 Spain 338 works
  10. 10 Türkiye 292 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 33.2%China: 23.2%India: 7.9%United Kingdom: 7.4%6 others listed: 28.4%33%largest
United States2,718 · 33.2%China1,899 · 23.2%India648 · 7.9%United Kingdom607 · 7.4%6 others listed2,328 · 28.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Breast Cancer Treatment Studies research?

By volume in 2022-now, Harvard University publishes the most Breast Cancer Treatment Studies research, followed by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center.

Who are the leading researchers in Breast Cancer Treatment Studies?

The most-cited researchers publishing on Breast Cancer Treatment Studies include Douglas G. Altman, Ahmedin Jemal and Rebecca L. Siegel.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Rebecca L. Siegel United States 582k citations
  4. 4 Freddie Bray France 550k citations
  5. 5 Walter Churchill Willett United States 411k citations
  6. 6 Stacey L. Gabriel United States 402k citations
  7. 7 Robert John Tibshirani United States 396k citations
  8. 8 Gad A. Getz United States 364k citations
  9. 9 Elaine R. Mardis United States 346k citations
  10. 10 Hermann Brenner Germany 343k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Breast Cancer Treatment Studies?

The most cited paper in Breast Cancer Treatment Studies is "New Guidelines to Evaluate the Response to Treatment in Solid Tumors" (Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al., 2000), with 15,773 citations. Next come "Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer" (13,212) and "Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2" (11,628).

Most cited papers
#PaperReleasedCitations
1 New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute 2 Feb 2000 15,773
2 Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology Open access 2013 13,212
3 Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 Dennis J. Slamon, Brian R Leyland-Jones, Steven Shak et al. · New England Journal of Medicine Open access 15 Mar 2001 11,628
4 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Thérese Sørlie, Charles M. Perou, Robert John Tibshirani et al. · Proceedings of the National Academy of Sciences Open access 11 Sep 2001 11,073
5 Gene expression profiling predicts clinical outcome of breast cancer Laura van ‘t Veer, Hongyue A. Dai, Marc J. van de Vijver et al. · Nature Open access 2002 9,661
All 100 most cited papers, with filters and sorting

Where is Breast Cancer Treatment Studies research done?

The largest centres of Breast Cancer Treatment Studies research in 2022-now are New York (United States), Seoul (South Korea), Beijing (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano.

Largest cities, 2022-now

  1. 1 New YorkUnited States 231 works
  2. 2 SeoulSouth Korea 223 works
  3. 3 BeijingChina 217 works
  4. 4 ShanghaiChina 177 works
  5. 5 LondonUnited Kingdom 165 works
  6. 6 BostonUnited States 157 works
  7. 7 GuangzhouChina 147 works
  8. 8 HoustonUnited States 141 works
  9. 9 TokyoJapan 119 works
  10. 10 RomeItaly 111 works

Where it is the local speciality

  1. RozzanoIT · 26.9 works15×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Breast Cancer Treatment Studies than the world average.

See Breast Cancer Treatment Studies on the map

Where is the best place to study Breast Cancer Treatment Studies?

Among universities, judged by research, Harvard University, Humanitas University and Karolinska Institutet score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.75%fractional works in this field (log) →share of work in the world top 10% →Humanitas UniversityInstitute of Cancer …Harvard UniversityKarolinska Institutet
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 81.018.0%5.1×165 -3.0%
2Humanitas UniversityItaly 75.922.0%16.8×25 +74.2%
3Karolinska InstitutetSweden 73.015.6%7.0×41 +15.8%
4Institute of Cancer ResearchUnited Kingdom 66.719.6%33.5×11 +3.4%
5Sun Yat-sen UniversityChina 65.816.1%3.9×83 +11.4%
6Harbin Medical UniversityChina 64.317.4%10.3×36 +139.5%
7University of California, San FranciscoUnited States 63.413.6%5.7×42 +2.9%
8Royal College of Surgeons in IrelandIreland 62.115.2%10.9×11 +68.2%
9McGill UniversityCanada 62.014.0%2.8×29 +29.3%
10Università Cattolica del Sacro CuoreItaly 61.716.0%7.9×35 +54.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Breast Cancer Treatment Studies, country by country

Is Breast Cancer Treatment Studies research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Breast Cancer Treatment Studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Breast Cancer Treatment Studies as a percentage of every work published that year, 0.047% in 2024.

still counting0.025%0.050%0.075%Breast Cancer Treatment Studies0.046% in 202519801990200020102020

Fractional works of Breast Cancer Treatment Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Breast Cancer Treatment Studies10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Which institutions lead breast cancer research?

By volume in 2022-now, Harvard University publishes the most Breast Cancer Treatment Studies research, followed by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center.

Which institutions lead Breast Cancer Treatment Studies research?
All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Breast Cancer Treatment Studies. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.